Biologics

So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches to research breakthroughs, here are the biggest developments to know: 1. Evanston, Ill.-based Northwestern University scientists have created the most…

Medtronic’s Infuse bone graft earned the FDA’s premarket approval for one- and two-level transforaminal lumbar interbody spinal fusions. The expanded approval allows use with PEEK and titanium interbody cages, according to a Feb. 17 news release. Infuse is now the…

Vivex Biologics’ VIA Form+ cryopreserved viable bone allograft saw 100% radiograhpic fusion success within six months of surgery, according to a study in the Journal of Spine & Neurosurgery. Five things to know: 1. The study followed 14 patients who…

Orthobiologics company Ossio closed $50 million in credit facility from Horizon Technology Finance and Monroe Capital, according to a Feb. 11 news release. The deal includes initial $40 million senior credit facility for Ossio, along with an additional $10 million…

Evanston, Ill.-based Northwestern University scientists have created the most advanced human spinal cord injury organoid model to date, enabling researchers to test regenerative therapies in lab-grown tissue, according to a study published Feb. 11 in Nature Biomedical Engineering. The team…

CartiNova, a regenerative medicine clinic focused on orthopedic and spine care, has launched in Atlanta. Founded by Trevor Turner, MD, a regenerative orthopedics physician, the practice offers minimally invasive, in-office procedures for knee and spine conditions as an alternative to…

Regenerative medicine now sits in a complicated place in orthopedic care. Patients ask about it routinely. Clinics promote it aggressively. Stories of injections replacing surgery circulate widely online. Platelet-rich plasma and stem cell-based therapies have become part of the orthopedic…

Orthofix introduced its Biologics Surgeon Advisory Board which includes seven spine surgeons, according to a Feb. 4 news release. The board includes experts in orthopedic spine and spinal neurosurgery, and they were chosen based on their clinical experience, leadership in…

NanoFuse bioactive glass–demineralized bone matrix composite was found to be stronger than DBM alone or bioactive glass alone, according to a study in the International Journal of Spine Surgery. Researchers examined whether combining DBM and bioactive glass could produce a…

Kolosis Bio and nonprofit MTF Biologics are launching Summit Matrix, a synthetic bone graft for spine and orthopedic surgeries. The bone graft is supported by NanoLift surface technology and designed to improve bone regeneration, according to a Jan. 14 news…